MA46205A - Composés 1,2-dithiolane utiles dans la neuroprotection, les maladies et les états auto-immuns et cancéreux - Google Patents

Composés 1,2-dithiolane utiles dans la neuroprotection, les maladies et les états auto-immuns et cancéreux

Info

Publication number
MA46205A
MA46205A MA046205A MA46205A MA46205A MA 46205 A MA46205 A MA 46205A MA 046205 A MA046205 A MA 046205A MA 46205 A MA46205 A MA 46205A MA 46205 A MA46205 A MA 46205A
Authority
MA
Morocco
Prior art keywords
neuroprotection
autoimmune
diseases
compounds useful
cancer conditions
Prior art date
Application number
MA046205A
Other languages
English (en)
Inventor
Collen E Evans
Tarek S Mansour
Original Assignee
Sabila Biosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sabila Biosciences Llc filed Critical Sabila Biosciences Llc
Publication of MA46205A publication Critical patent/MA46205A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/257—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/29—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA046205A 2016-09-08 2017-09-08 Composés 1,2-dithiolane utiles dans la neuroprotection, les maladies et les états auto-immuns et cancéreux MA46205A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662384813P 2016-09-08 2016-09-08

Publications (1)

Publication Number Publication Date
MA46205A true MA46205A (fr) 2019-07-17

Family

ID=61562330

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046205A MA46205A (fr) 2016-09-08 2017-09-08 Composés 1,2-dithiolane utiles dans la neuroprotection, les maladies et les états auto-immuns et cancéreux

Country Status (5)

Country Link
US (1) US10844038B2 (fr)
EP (1) EP3509599A4 (fr)
JP (1) JP7201586B6 (fr)
MA (1) MA46205A (fr)
WO (1) WO2018049127A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3740491A1 (fr) 2018-01-18 2020-11-25 Array Biopharma, Inc. Composés de pyrrolo[2,3-d]pyrimidines substitués utilisés en tant qu'inhibiteurs de la kinase ret
EP3740486A1 (fr) 2018-01-18 2020-11-25 Array Biopharma, Inc. Composés de pyrazolyl[4,3-c]pyridine substitués utilisés en tant qu'inhibiteurs de la kinase ret
CN111630054B (zh) * 2018-01-18 2023-05-09 奥瑞生物药品公司 作为RET激酶抑制剂的取代的吡唑并[3,4-d]嘧啶化合物
CA3108065C (fr) 2018-07-31 2025-10-07 Loxo Oncology, Inc. Dispersions séchées par pulvérisation, formulations et polymorphies de (s)-5-amino-3-(4-((5 fluoro-2-méthoxybenzamido)méthyle)phényle)(1,1,1-trifluoropropane-2-yl)-1h-pyrazole-4-carboxamide
CN109134472B (zh) * 2018-09-20 2020-02-11 浙江理工大学 一种3-(4-苯氧基苯基)-1H-吡唑并[3,4-d]嘧啶-4-胺的合成工艺
KR20210145773A (ko) 2019-03-28 2021-12-02 지앙수 헨그루이 메디슨 컴퍼니 리미티드 티에노헤테로고리형 유도체, 이의 제조 방법 및 이의 의약적 용도
WO2020200069A1 (fr) 2019-03-29 2020-10-08 江苏恒瑞医药股份有限公司 Dérivé pyrrolohétérocyclique, son procédé de préparation et son application en médecine
EP3950685A4 (fr) 2019-04-03 2022-12-14 Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory Composé de pyrazolopyridine utilisé comme inhibiteur de ret et son application
EP3978498A1 (fr) 2019-05-24 2022-04-06 Jiangsu Hengrui Medicine Co., Ltd. Dérivé bicyclicque condensé substituté, son procédé de préparation et son application en médecine
US20230331731A1 (en) 2020-09-29 2023-10-19 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Crystal form of pyrrolo heterocyclic derivative and preparation method therefor
ES3072864T3 (en) * 2020-09-29 2026-07-06 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Baiyunshan Pharmaceutical General Factory Crystal forms of pyridopyrazole compounds and preparation method therefor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993002076A1 (fr) * 1991-07-18 1993-02-04 Kyowa Hakko Kogyo Co., Ltd. Compose de 1,2-dithiolane
EP2139487B1 (fr) * 2007-03-28 2015-11-11 Pharmacyclics LLC Inhibiteurs de la tyrosine kinase de bruton
US8242271B2 (en) * 2007-06-04 2012-08-14 Avila Therapeutics, Inc. Heterocyclic compounds and uses thereof
US8476431B2 (en) * 2008-11-03 2013-07-02 Itellikine LLC Benzoxazole kinase inhibitors and methods of use
EP3069612A3 (fr) 2009-06-15 2016-10-19 Encore Health, LLC Composés dithiols, dérivés et leurs utilisations
WO2011141909A2 (fr) * 2010-05-10 2011-11-17 Radikal Therapeutics Inc. Dérivés d'acide lipoïque et de nitroxide et leurs utilisations
US8377946B1 (en) * 2011-12-30 2013-02-19 Pharmacyclics, Inc. Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
WO2014078623A2 (fr) * 2012-11-15 2014-05-22 Brandeis University Amarrage de résidus de cystéine à l'aide de bisulfures cycliques

Also Published As

Publication number Publication date
JP2019534857A (ja) 2019-12-05
US20200010442A1 (en) 2020-01-09
WO2018049127A1 (fr) 2018-03-15
JP7201586B2 (ja) 2023-01-10
US10844038B2 (en) 2020-11-24
EP3509599A1 (fr) 2019-07-17
EP3509599A4 (fr) 2020-02-19
CA3036079A1 (fr) 2018-03-15
JP7201586B6 (ja) 2024-02-08

Similar Documents

Publication Publication Date Title
FR23C1047I2 (fr) Composés pyrimidinedione contre les maladies cardiaques
EP3464313A4 (fr) Nucléotides modifiés 5 '-cyclo-phosphonate
SI3394094T1 (sl) T celični receptorji, specifični za NY-ESO-1 tumorski kompleks antigen-HLA-A*02
HRP20181796T1 (hr) Derivati naftiridina kao antagonisti alfa v beta 6 integrina, namijenjeni liječenju, primjerice, fibrotičnih bolesti
HUE047806T2 (hu) Kombinációs kezelés tumort célzó IL-2-variáns immuncitokinekkel és humán PD-L1 elleni antitestekkel
EP3509599A4 (fr) Composés 1,2-dithiolane utiles dans la neuroprotection, les maladies et les états auto-immuns et cancéreux
EP3829420A4 (fr) Fluorophores épargnant les nerfs en proche infrarouge
EP3723787A4 (fr) Récepteurs de l'interleukine darique
DK3720433T3 (da) Bis-cholin-tetrathiomolybdat til behandling af wilsons sygdom
EP3506863A4 (fr) Applicateurs d'implant
EP3346955A4 (fr) Amélioration de la circulation de l'air dans les poumons
EP3401771A4 (fr) Interface d'interaction intelligente
GB201701480D0 (en) Disease resistance
FR3027881B1 (fr) Temoin d'ouverture de manchon thermo-retractable
DK3417732T3 (da) Sko med fodstimulerende indretning
ES1186733Y (es) Percha calefactora
FR3032587B1 (fr) Panneau de chauffage et d'eclairage
FR3026952B1 (fr) Extrait organique de bulbe de lilium pour son utilisation dans les desordres ou pathologies de la peau
ITUB20154699A1 (it) Abito tromp l'oeil.
GB201808734D0 (en) Trousers to facilitate urination
IT201700046472U1 (it) Fresa "Stair/Slide"
IT201700041122U1 (it) "io come te"
UA35960S (uk) М'ясорубка
ES1165833Y (es) Lona emergencias sanitarias
ES1139511Y (es) "Manillar de empuñaduras articuladas"